Market Cap 31.07M
Revenue (ttm) 32.55M
Net Income (ttm) -6.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18.99%
Debt to Equity Ratio 0.23
Volume 756,600
Avg Vol 1,754,744
Day's Range N/A - N/A
Shares Out 38.44M
Stochastic %K 18%
Beta 1.48
Analysts Strong Sell
Price Target $5.10

Company Profile

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interfac...

Industry: Medical Devices
Sector: Healthcare
Phone: 617 996 9058
Website: myomo.com
Address:
45 Blue Sky Dr., Suite 101, Burlington, United States
krueb
krueb Nov. 14 at 4:59 PM
$MYO true 😂
0 · Reply
NickMitchell
NickMitchell Nov. 14 at 2:37 PM
$MYO Bankruptcy next, RiP
0 · Reply
R0tt3n
R0tt3n Nov. 14 at 1:31 AM
$MYO tell us again how you worked for billy bob satan gates. It makes everything you post that much more believable and trust worth 🤡
1 · Reply
R0tt3n
R0tt3n Nov. 14 at 1:28 AM
$MYO “no I’m not shorting the stock” - I’m just spending every moment of my awake life on stocktwits b*tching about said stock trying to convince everyone to sell it🤣 fking 🤡
1 · Reply
Astondb9
Astondb9 Nov. 13 at 5:22 PM
$MYO for you technical junkies, here is the actual play. Inverse cup n handle. Once it loses $.80, look out below!!!
1 · Reply
Astondb9
Astondb9 Nov. 13 at 5:16 PM
$MYO I'll spare the more detailed path. I drew a descending channel months and months ago and warned do not buy until it gets out of that defined selling channel. Well if you bought without listening to my advice, then you lost $ and became liquidity for the bears. It has not once broken out of the selling channel since the shit show began at $3. Rightfully so. Look at the horrendous fundamentals. You cant simply apply a rev multiples for perpetuity especially when their ocf-, cogs is 6x growth rate (abyssmal), bleeding cash, and mgt sucks. Where is this headed? Once it loses $.80, $.47 is support. Look at the weekly. Bottom bb is $.37! So if youre long, why? What part of that earnings release was bullish? Zero.
2 · Reply
Astondb9
Astondb9 Nov. 13 at 4:35 PM
$MYO 💩🤡🙈
1 · Reply
DeanJ7575
DeanJ7575 Nov. 13 at 2:52 PM
$MYO by the time this stupid company and dumb Management gets their shit together they will find a cure with a pill to bring back motion!
0 · Reply
abira
abira Nov. 13 at 2:20 PM
$MYO Myomo started a large clinical study with Utah University (https://neurorobotics.ece.utah.edu/2025/08/01/new-clinical-trial-for-upper-limb-exoskeleton/) . Not sure whether this study for a new iteration of Myomo, or for the existing model.
1 · Reply
abira
abira Nov. 13 at 2:16 PM
$MYO Caleb Thomson started work at Myomo as a R&D Engineer after getting his Ph.D. from Utah University. His dissertation focuses on whether a patient could, for example, grasp an object while also flexing their wrist, and control the amount of force proportionally, rather than just "on/off." https://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=11124928 (the answer is yes, this is possible and functional for patients). Such capabilities could potentially be part of Myomo 3.0
0 · Reply
Latest News on MYO
Myomo, Inc. (MYO) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 10:41 PM EST - 4 days ago

Myomo, Inc. (MYO) Q3 2025 Earnings Call Transcript


Myomo, Inc. (MYO) Q2 2025 Earnings Conference Call Transcript

Aug 11, 2025, 6:56 PM EDT - 3 months ago

Myomo, Inc. (MYO) Q2 2025 Earnings Conference Call Transcript


Myomo, Inc. (MYO) Q1 2025 Earnings Call Transcript

May 7, 2025, 9:00 PM EDT - 6 months ago

Myomo, Inc. (MYO) Q1 2025 Earnings Call Transcript


Myomo to Host Investor & Analyst Day Event on June 18, 2025

May 1, 2025, 8:30 AM EDT - 7 months ago

Myomo to Host Investor & Analyst Day Event on June 18, 2025


Myomo to Report First Quarter 2025 Financial Results on May 7

Apr 30, 2025, 4:05 PM EDT - 7 months ago

Myomo to Report First Quarter 2025 Financial Results on May 7


Myomo Launches the MyoPro® 2x

Apr 30, 2025, 8:05 AM EDT - 7 months ago

Myomo Launches the MyoPro® 2x


Myomo Announces Upcoming Changes to its Board of Directors

Apr 10, 2025, 8:30 AM EDT - 7 months ago

Myomo Announces Upcoming Changes to its Board of Directors


Myomo, Inc. (MYO) Q4 2024 Earnings Call Transcript

Mar 10, 2025, 6:13 PM EDT - 8 months ago

Myomo, Inc. (MYO) Q4 2024 Earnings Call Transcript


Myomo, Inc. (MYO) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 10:11 PM EST - 1 year ago

Myomo, Inc. (MYO) Q3 2024 Earnings Call Transcript


CMS Decision And O&P Network Build Out Make Myomo A Buy

Nov 5, 2024, 3:30 PM EST - 1 year ago

CMS Decision And O&P Network Build Out Make Myomo A Buy


Myomo, Inc. (MYO) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 11:03 AM EDT - 1 year ago

Myomo, Inc. (MYO) Q2 2024 Earnings Call Transcript


Myomo Reports Second Quarter 2024 Financial Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Myomo Reports Second Quarter 2024 Financial Results


Myomo, Inc. (MYO) Q1 2024 Earnings Call Transcript

May 8, 2024, 10:03 PM EDT - 1 year ago

Myomo, Inc. (MYO) Q1 2024 Earnings Call Transcript


Myomo Reports First Quarter 2024 Financial Results

May 8, 2024, 4:05 PM EDT - 1 year ago

Myomo Reports First Quarter 2024 Financial Results


Myomo Appoints Heather Getz to its Board of Directors

Mar 28, 2024, 4:05 PM EDT - 1 year ago

Myomo Appoints Heather Getz to its Board of Directors


Myomo, Inc.: In Motion To Accelerating Revenue Growth

Mar 10, 2024, 3:00 AM EDT - 1 year ago

Myomo, Inc.: In Motion To Accelerating Revenue Growth


Myomo, Inc. (MYO) Q4 2023 Earnings Call Transcript

Mar 7, 2024, 8:10 PM EST - 1 year ago

Myomo, Inc. (MYO) Q4 2023 Earnings Call Transcript


Myomo Reports Preliminary Fourth Quarter Revenue and Backlog

Jan 17, 2024, 8:00 AM EST - 1 year ago

Myomo Reports Preliminary Fourth Quarter Revenue and Backlog


Myomo: Market Severely Undervaluing Opportunity

Dec 1, 2023, 1:32 PM EST - 2 years ago

Myomo: Market Severely Undervaluing Opportunity


Myomo, Inc. (MYO) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 6:28 PM EST - 2 years ago

Myomo, Inc. (MYO) Q3 2023 Earnings Call Transcript


krueb
krueb Nov. 14 at 4:59 PM
$MYO true 😂
0 · Reply
NickMitchell
NickMitchell Nov. 14 at 2:37 PM
$MYO Bankruptcy next, RiP
0 · Reply
R0tt3n
R0tt3n Nov. 14 at 1:31 AM
$MYO tell us again how you worked for billy bob satan gates. It makes everything you post that much more believable and trust worth 🤡
1 · Reply
R0tt3n
R0tt3n Nov. 14 at 1:28 AM
$MYO “no I’m not shorting the stock” - I’m just spending every moment of my awake life on stocktwits b*tching about said stock trying to convince everyone to sell it🤣 fking 🤡
1 · Reply
Astondb9
Astondb9 Nov. 13 at 5:22 PM
$MYO for you technical junkies, here is the actual play. Inverse cup n handle. Once it loses $.80, look out below!!!
1 · Reply
Astondb9
Astondb9 Nov. 13 at 5:16 PM
$MYO I'll spare the more detailed path. I drew a descending channel months and months ago and warned do not buy until it gets out of that defined selling channel. Well if you bought without listening to my advice, then you lost $ and became liquidity for the bears. It has not once broken out of the selling channel since the shit show began at $3. Rightfully so. Look at the horrendous fundamentals. You cant simply apply a rev multiples for perpetuity especially when their ocf-, cogs is 6x growth rate (abyssmal), bleeding cash, and mgt sucks. Where is this headed? Once it loses $.80, $.47 is support. Look at the weekly. Bottom bb is $.37! So if youre long, why? What part of that earnings release was bullish? Zero.
2 · Reply
Astondb9
Astondb9 Nov. 13 at 4:35 PM
$MYO 💩🤡🙈
1 · Reply
DeanJ7575
DeanJ7575 Nov. 13 at 2:52 PM
$MYO by the time this stupid company and dumb Management gets their shit together they will find a cure with a pill to bring back motion!
0 · Reply
abira
abira Nov. 13 at 2:20 PM
$MYO Myomo started a large clinical study with Utah University (https://neurorobotics.ece.utah.edu/2025/08/01/new-clinical-trial-for-upper-limb-exoskeleton/) . Not sure whether this study for a new iteration of Myomo, or for the existing model.
1 · Reply
abira
abira Nov. 13 at 2:16 PM
$MYO Caleb Thomson started work at Myomo as a R&D Engineer after getting his Ph.D. from Utah University. His dissertation focuses on whether a patient could, for example, grasp an object while also flexing their wrist, and control the amount of force proportionally, rather than just "on/off." https://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=11124928 (the answer is yes, this is possible and functional for patients). Such capabilities could potentially be part of Myomo 3.0
0 · Reply
R0tt3n
R0tt3n Nov. 12 at 11:15 PM
$MYO alright. Well in that case , and if we’re just reading charts, this is bouncing off .8 range and going back to 4-5 bucks.
1 · Reply
fitchbuck
fitchbuck Nov. 12 at 8:00 PM
$MYO oh really?? Waylin nailed this on the way up. He nailed it on the sell-off. Then he crushed it with his calls on APLD and VKTX, in fact I wish I had listened to this pied-piper hella more in the last year.
1 · Reply
abira
abira Nov. 12 at 4:31 PM
$MYO Rosalind kept its 9.99% position in Myomo
1 · Reply
Rroper
Rroper Nov. 12 at 3:40 PM
$MYO Me thinks this will dip lower to the .50 range before it recovers. Paytience to load more from my perspective.
0 · Reply
Big_Baggies
Big_Baggies Nov. 12 at 3:37 PM
$MYO Pursuant to the Loan Agreement, the Lender also has the right to convert up to $3.0 million of the outstanding principal of Tranche 1 and up to $1.0 million of the outstanding principal of Tranche 2 into shares of Company common stock (the “Conversion Securities”) at a price per share equal to 120% of the exercise price of the Warrant (further discussed below) at any time while the Loans are outstanding Warrant On the Closing Date and pursuant to the funding of Tranche 1 under the Loan Agreement, the Company issued to the Lender a warrant to purchase up to$1 ,312,500 worth of shares of the Company’s common stock (the “Warrant”). The Warrant expires on November 4, 2030 (the “Expiration Date”) and has an exercise price per share equal to the lesser of (i) $0.96 and (ii) the price per share of the Company’s next bona fide round of equity financing before June 30, 2026 for the purposes of raising capital
2 · Reply
R0tt3n
R0tt3n Nov. 11 at 10:11 PM
$MYO reading a chart isn’t going to help you one iota in a play like this. 🤣
1 · Reply
Amorrr
Amorrr Nov. 11 at 6:55 PM
$MYO hope you covered
2 · Reply
kurtb1969
kurtb1969 Nov. 11 at 6:38 PM
$MYO all the shorts are desperate, if you bought under 87 congratulations. We will have a lot on insider buying next few weeks. Dilution is not happening they have $20 million cash which may get them to profitability. Less than 1x sales is a ridiculously low valuation for a company averaging over 50 percent growth over past 3 years.
2 · Reply
GaryGherkins
GaryGherkins Nov. 11 at 6:26 PM
$MYO you know you’re in some bad investments when the dow is up 500 pts & you’re down for the day.
0 · Reply
krueb
krueb Nov. 11 at 5:21 PM
$MYO I still see it just stabilizing. Not really a case to be bullish in short term but not really a case to be bearish. patient money here will make money even if it takes two+ more years, just keep accumulating as you can. It’s old school long term speculative investment vs a quick moonshot.
2 · Reply
Astondb9
Astondb9 Nov. 11 at 3:28 PM
$MYO Hope you ssee that beautiful inverse cup line formed at $.80. When it loses $.80, guess where support is! You dont wanna know...$.50!
1 · Reply
kurtb1969
kurtb1969 Nov. 11 at 3:04 PM
$MYO insider buys should be announced this week. The window to buy just opened with quarterly report.
0 · Reply